284 related articles for article (PubMed ID: 6459843)
21. Differential effects of tranylcypromine and imidazole on mammary carcinogenesis in rats fed low and high fat diets.
McCormick DL; Spicer AM; Hollister JL
Cancer Res; 1989 Jun; 49(12):3168-72. PubMed ID: 2497973
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of growth of established N-methyl-N-nitrosourea-induced mammary cancer in rats by retinoic acid and ovariectomy.
Lacroix A; Doskas C; Bhat PV
Cancer Res; 1990 Sep; 50(18):5731-4. PubMed ID: 2393847
[TBL] [Abstract][Full Text] [Related]
23. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors.
Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM
Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393
[TBL] [Abstract][Full Text] [Related]
24. Role of estrogen and prolactin in stimulation of carcinogen-induced mammary tumor development by a high-fat diet.
Aylsworth CF; Van Vugt DA; Sylvester PW; Meites J
Cancer Res; 1984 Jul; 44(7):2835-40. PubMed ID: 6426788
[TBL] [Abstract][Full Text] [Related]
25. Modulation of rat mammary carcinogenesis by indomethacin.
McCormick DL; Madigan MJ; Moon RC
Cancer Res; 1985 Apr; 45(4):1803-8. PubMed ID: 3919946
[TBL] [Abstract][Full Text] [Related]
26. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis.
Ip C
Cancer Res; 1981 Nov; 41(11 Pt 1):4386-90. PubMed ID: 6796257
[TBL] [Abstract][Full Text] [Related]
27. Effect of an inorganic and organic form of dietary selenium on the promotional stage of mammary carcinogenesis in the rat.
Thompson HJ; Meeker LD; Kokoska S
Cancer Res; 1984 Jul; 44(7):2803-6. PubMed ID: 6722810
[TBL] [Abstract][Full Text] [Related]
28. Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis.
Abou-Issa H; Moeschberger M; el-Masry W; Tejwani S; Curley RW; Webb TE
Anticancer Res; 1995; 15(3):805-10. PubMed ID: 7645962
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor model.
Abou-Issa H; Curley RW; Panigot MJ; Tanagho SN; Sidhu BS; Alshafie GA
Anticancer Res; 1997; 17(5A):3335-9. PubMed ID: 9413168
[TBL] [Abstract][Full Text] [Related]
30. Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea.
McCormick DL; Adamowski CB; Fiks A; Moon RC
Cancer Res; 1981 May; 41(5):1690-4. PubMed ID: 7214338
[TBL] [Abstract][Full Text] [Related]
31. Anticarcinogenic and hepatotoxic interactions between retinyl acetate and butylated hydroxytoluene in rats.
McCormick DL; May CM; Thomas CF; Detrisac CJ
Cancer Res; 1986 Oct; 46(10):5264-9. PubMed ID: 3093062
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer.
Dowlatshahi K; Mehta RG; Thomas CF; Dinger NM; Moon RC
Cancer Lett; 1989 Oct; 47(3):187-92. PubMed ID: 2534548
[TBL] [Abstract][Full Text] [Related]
33. Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats.
Manjanatha M; Shelton S; Bishop M; Lyn-Cook L; Aidoo A
Carcinogenesis; 2006 Oct; 27(10):1970-9. PubMed ID: 16709578
[TBL] [Abstract][Full Text] [Related]
34. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro.
Welsch CW; DeHoog JV; Scieszka KM; Aylsworth CF
Cancer Res; 1984 Jan; 44(1):166-71. PubMed ID: 6360344
[TBL] [Abstract][Full Text] [Related]
35. Repeated administration of carcinogen in critical developmental periods increases susceptibility of female Wistar: han rats to mammary carcinogenesis induction.
Bojková B; Ahlers I; Kubatka P; Mociková K; Mníchová M; Ahlersová E
Neoplasma; 2000; 47(4):230-3. PubMed ID: 11043827
[TBL] [Abstract][Full Text] [Related]
36. Effect of combined selenium and retinyl acetate treatment on mammary carcinogenesis.
Thompson HJ; Meeker LD; Becci PJ
Cancer Res; 1981 Apr; 41(4):1413-6. PubMed ID: 7194139
[TBL] [Abstract][Full Text] [Related]
37. In vivo use of N-(4-hydroxyphenyl retinamide)-0-glucuronide as a breast cancer chemopreventive agent.
Abou-Issa H; Curley RW; Panigot MJ; Wilcox KA; Webb TE
Anticancer Res; 1993; 13(5A):1431-6. PubMed ID: 8239515
[TBL] [Abstract][Full Text] [Related]
38. Effect of short-term feeding of sodium selenite on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in the rat.
Thompson HJ; Meeker LD; Becci PJ; Kokoska S
Cancer Res; 1982 Dec; 42(12):4954-8. PubMed ID: 6814747
[TBL] [Abstract][Full Text] [Related]
39. Selenium inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis in the rat.
Thompson HJ; Becci PJ
J Natl Cancer Inst; 1980 Dec; 65(6):1299-301. PubMed ID: 6933274
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model.
Abou-Issa H; Webb TE; Minton JP; Moeschberger M
J Natl Cancer Inst; 1989 Dec; 81(23):1820-3. PubMed ID: 2531231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
